WALTHAM, Mass. (BUSINESS WIRE) Scipher Medicine, a precision immunology company matching each patient with their most effective therapy, today announced that Chief Financial Officer John Strumbos will participate in the virtual 11th Annual SVB Leerink Global Healthcare Conference, hosting investor meetings on Tues.
Scipher Medicine Appoints Dr Michael Elliott to its Science Advisory Board streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Industry Pioneer and Former Senior Vice President of Immunology at Janssen Pharmaceuticals Brings Decades of Experience in Autoimmune Diseases to Fast-Growing Precision Immunology CompanyWALTHAM, Mass. (BUSINESS WIRE) Scipher Medicine, a precision immunology company matching patients with their most effective ther.
Scipher Medicine Welcomes John Strumbos as Chief Financial Officer streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Immunovant Announces Voluntary Pause in Clinical Dosing of IMVT-1401
ImmunovantFebruary 2, 2021 GMT
NEW YORK, Feb. 02, 2021 (GLOBE NEWSWIRE) Immunovant (Nasdaq: IMVT), a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases, today announced a voluntary pause of dosing in its ongoing clinical trials for IMVT-1401.
The Company has become aware of a physiological signal consisting of elevated total cholesterol and LDL levels in IMVT-1401-treated patients in ASCEND GO-2, a Phase 2b trial in Thyroid Eye Disease (TED). Cholesterol levels were not measured in prior clinical trials of IMVT-1401 in Myasthenia Gravis (MG) and in healthy subjects. Out of an abundance of caution, the Company has decided to voluntarily pause dosing in ongoing clinical studies in both TED and in Warm Autoimmune Hemolytic Anemia, in order to inform patients,